For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com  Inclusion Criteria:  - Previously completed open-label extension treatment in one of the parent Crohn's disease or ulcerative colitis studies  Exclusion Criteria:  - Any disease or medical condition that, in the opinion of the investigator, would make the participant unsuitable for this study, would interfere with the interpretation of participant safety or study results, or is considered unsuitable by the investigator for any other reason  Other protocol-defined inclusion/exclusion criteria apply